Search This Blog

Tuesday, August 13, 2019

Myriad Genetics EPS misses by $0.07, misses on revenue

Myriad Genetics (NASDAQ:MYGN): Q4 Non-GAAP EPS of $0.41 misses by $0.07; GAAP EPS of -$0.06.
Revenue of $215.4M (+11.1% Y/Y) misses by $6.24M.
Shares -5.6%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)